Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Crypto market maker B2C2 launches stablecoin exchange platform Penny, supporting institutional cross-chain stablecoin swaps

Crypto market maker B2C2 launches stablecoin exchange platform Penny, supporting institutional cross-chain stablecoin swaps

ForesightNewsForesightNews2025/10/23 13:02
Show original

Foresight News reported, according to CoinDesk, that crypto market maker B2C2 has launched a stablecoin exchange platform called Penny, aiming to support instant, zero-fee swaps between stablecoins such as USDT, USDC, and PYUSD. This service is targeted at institutions and offers on-chain settlement across Ethereum, Tron, Solana, and Layer 2 networks. Currently, PENNY supports six stablecoins—USDT, USDC, USDG, RLUSD, PYUSD, and AUSD—on Ethereum, Tron, Solana, and several Layer 2 networks, with plans to regularly add more assets.


B2C2 stated that PENNY allows users—including banks, merchant acquirers, exchanges, and stablecoin infrastructure companies—to automatically swap between tokens without paying fees or taking on counterparty risk.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency

The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.

智通财经•2026/11/12 02:26

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07